The United States dialysis equipment business size is expected to expand from US$ 6,495.4 million in 2024 to US$ 8,690.2 million by 2034. Demand for dialysis equipment in the United States is anticipated to grow at a CAGR of 3.0%. In 2023, the United States dialysis equipment business revenue totaled US$ 6,252.5 million, and it is set to increase at a Y-o-Y growth of 3.5% in 2024.
United States Dialysis Equipment Industry Outlook
| Attributes | Key Insights |
|---|---|
| United States Dialysis Equipment Business Value in 2023 | US$ 6,252.5 million |
| Estimated Value in 2024 | US$ 6,495.4 million |
| Projected Value in 2034 | US$ 8,690.2 million |
| Value CAGR (2024 to 2034) | 3.0% |
The trend toward home-based dialysis and expansion of telemedicine & remote monitoring technologies represents a transformative shift in renal care. This is expected to persist and expand and will play a key role in fostering growth of the dialysis equipment in the United States.
Home-based dialysis, such as peritoneal dialysis and home hemodialysis, provides numerous advantages. These include enhanced patient convenience, improved quality of life, and a reduced burden on healthcare facilities.
Rising demand for dialysis equipment that is user-friendly and capable of supporting remote treatment is set to boost sales. To benefit from this, companies will look to introduce novel home-based dialysis systems with enhanced features.
Growing government initiatives to support manufacturers as well as end users for dialysis are expected to boost sales growth. Subsequently, favorable reimbursement policies are predicted to make the United States a highly lucrative pocket for dialysis equipment companies.
The United States government is establishing guidelines for dialysis with the aim of better accessibility of dialysis, which can be undertaken in home settings. This is especially beneficial for patients in rural areas who have to incur additional costs traveling to dialysis centers in faraway places.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue in the United is predicted to expand over 1.3X through 2033, amid a 0.5% increase in anticipated CAGR compared to the historical one. This is due to rising incidence of kidney diseases and rising demand for advanced dialysis treatments.
Other Factors and Trends in the United States Dialysis Equipment Business Shaping Growth include:
Sales of dialysis equipment in the United States recorded a CAGR of 2.5% from 2019 to 2023. Total valuation at the end of 2023 reached about US$ 6,252.5 million. Over the forecast period, the United States dialysis equipment business is set to thrive at 3.0% CAGR.
| Historical CAGR (2019 to 2023) | 2.5% |
|---|---|
| Forecast CAGR (2024 to 2034) | 3.0% |
Growing demand for dialysis amid increasing cases of kidney diseases, including CKD and ESRD, is expected to boost the dialysis equipment business. Dialysis systems are increasingly used in blood purification and the removal of extra fluid.
The United government strives to provide easy access to treatments for kidney patients. It is investing vast amounts in upgrading hospital infrastructure and technologies. This is expected to create growth prospects for dialysis equipment manufacturers.
Companies and researchers are trying to introduce novel dialysis systems with enhanced features. For instance, they are focusing on developing wearable dialysis machines that are convenient to use and free patients from the otherwise huge machines that keep them tied down.
Several companies in the United States are developing different types of wearable kidneys. These include devices for hemodialysis and peritoneal dialysis and one machine that combines both hemodialysis and peritoneal dialysis.
The new devices weigh less and have small parts fitted with long-lasting batteries and filters that can reuse dialysate without needing a lot of purified water. These advances make it possible for people to wear a dialysis device that isn’t very heavy and can be worn under clothing.
Principal Consultant
Manufacturers see an opportunity to connect symptoms and treatment algorithms. This is because they focus on the Advancing American Kidney Health Initiative’s goal of placing new dialysis patients on home dialysis in the coming years.
With government-supported programs like KidneyX, manufacturers see redesigning dialysis machines and connective health as ways to make treatments easier for patients and to provide useful data to clinicians. This will help them to boost their revenue and solidify their positions.
Healthcare organizations in the United States are taking several initiatives to reduce the burden of kidney diseases. For instance, in July 2020, HHS and ASN formed the KidneyX Innovation Accelerator (KidneyX). This partnership aims to disrupt the status quo and offer new hope to millions worldwide with kidney diseases. Such developments are expected to foster growth.
Growing prevalence of chronic diseases is prompting manufacturers to develop innovative dialysis products to meet customers’ demands. Thus, growing research and innovation of new products will offer lucrative opportunities for dialysis equipment manufacturers through 2034.
Overview of Restrictive Factors for the Dialysis Equipment Business
Kidney transplantation is one of the alternate treatment options for patients suffering from end-stage renal kidney disease. The better treatment outcomes associated with kidney transplants and affordability of the procedure, owing to the favorable reimbursement policies, are projected to impede the growth of the dialysis equipment business during the forecast period.
Patients diagnosed with ESRD prefer kidney transplantation over renal infusion owing to the long-term benefits associated with the procedure. Thus, growing preference for alternate treatment options over dialysis is expected to hamper the business’s growth in the coming years.
The need for frequent treatments makes dialysis a high-cost procedure that imposes a financial burden on patients. This may lower the adoption of the treatment.
The table below highlights the anticipated growth rates of different regions in the United States. Among these, Midwest and Southwest regions are set to register higher with CAGRs of 4.9% and 4.1%, respectively.
| Regions | Value-based CAGR |
|---|---|
| Northeast United States | 3.2% |
| Midwest United States | 4.9% |
| Southeast United States | 1.8% |
| Southwest United States | 4.1% |
| West United States | 2.5% |
The Southeast United States dominates the target business with a 34.5% value share in 2023. Over the forecast period, demand for dialysis equipment in the Southeast United States is predicted to rise at 1.8% CAGR.
Rising prevalence of chronic kidney diseases (CKD) is a prominent factor expected to drive dialysis equipment demand in the Southeast United States. As the number of patients requiring dialysis increases, so does the need for advanced and efficient equipment.
The Southeast United States is also witnessing increased investments in healthcare infrastructure, including dialysis centers and hospitals. Infrastructure development can support the integration of the latest dialysis equipment and technologies. This will likely boost sales of dialysis equipment in the region.
The West United States is expected to hold a value share of 23.0% in 2023. It will attain a valuation of US$ 1,913.6 million in 2033, with dialysis equipment sales growing at 2.5% CAGR throughout the assessment period.
Multiple factors are expected to drive sales growth in the West United States. These include rising popularity of home healthcare and growing adoption of portable dialysis equipment.
Integrating telehealth solutions in the West United States for remote monitoring and management of dialysis patients could present opportunities for manufacturers. Collaborations with healthcare providers, research institutions, and other stakeholders can foster innovation and the development of tailored solutions that meet regional needs.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below section highlights the estimated CAGR of key segments. The hemodialysis devices segment is projected to lead the target business through 2034, exhibiting a CAGR of 2.7%. The standalone dialysis equipment segment is predicted to generate significant revenue, registering a CAGR of 2.8%.
By indication, the ESRD segment is set to hold a dominant value share, thriving at 2.0% CAGR through 2034. Hospitals are expected to remain leading end users of dialysis equipment across the United States. The target segment will likely grow at a CAGR of 1.6% through 2034.
Growth Outlook by Key Product
| Product | Value CAGR |
|---|---|
| Hemodialysis Devices | 2.7% |
| Peritoneal Dialysis Devices | 4.7% |
| Continuous Renal Replacement Therapy Systems | 2.1% |
As per the latest analysis, demand for hemodialysis devices in the United States remains high. The target segment is estimated to thrive at 2.7% CAGR during the assessment period, holding a revenue share of 87.7% in 2023.
Growing popularity of hemodialysis is a prominent factor driving demand for hemodialysis systems in the United States. Similarly, rising demand for in-center hemodialysis machines and home hemodialysis machines will likely foster segment growth.
Hemodialysis has long been established as a primary method for treating ESRD, and the use of hemodialysis devices is integral to this treatment process. They are used to remove waste products and excess fluid from the blood.
Hemodialysis systems are designed to ensure clinical efficiency and patient safety during dialysis procedures. Their features, such as precise monitoring capabilities and safety mechanisms, contribute to improved treatment outcomes and patient well-being.
Peritoneal dialysis devices segment, on the other hand, is set to witness a higher CAGR of 4.7% through 2034. This is attributable to rising adoption of peritoneal dialysis equipment in the United States thriving healthcare sector.
Growth Outlook by Key Indication
| Indication | Value CAGR |
|---|---|
| Acute Kidney Injury (AKI) | 4.5% |
| Chronic Kidney Disease (CKD) | 3.3% |
| End Stage Renal Disease (ESRD) | 2.0% |
Based on indication, the ESRD segment is expected to generate significant revenue-generation opportunities for dialysis equipment manufacturers. This is attributable to rising prevalence of ESRD in the United States, along with growing need for effective treatments like dialysis for this condition.
The end stage renal disease (ESRD) segment is poised to exhibit a CAGR of 2.0% during the forecast period. It will likely total US$ 3,696.7 million in 2034.
The increasing prevalence of ESRD in the United States is a primary factor driving demand for dialysis equipment. Factors such as the aging population, rising incidences of diabetes and hypertension, and lifestyle-related diseases are contributing to the growing number of patients requiring dialysis treatment for ESRD.
Healthcare providers and dialysis equipment manufacturers have been increasingly focused on improving patient outcomes and improving individuals' quality of life with ESRD. This emphasis has led to the development of advanced and specialized dialysis equipment that can cater to the specific needs and preferences of patients undergoing dialysis treatment for ESRD.
Growth Outlook by Key Modality
| Modality | Value CAGR |
|---|---|
| Portable | 4.1% |
| Standalone | 2.8% |
As per the latest analysis, standalone dialysis equipment segment is projected to generate significant revenue in the United States. It is expected to thrive at 2.8% CAGR during the assessment period, holding a revenue share of 89.0% in 2024.
Several factors are making standalone systems a top revenue-generating modality segment across the United States. These include rising demand for sophisticated dialysis equipment from hospitals and clinics and innovations in standalone dialysis systems.
Standalone dialysis equipment are more powerful than portable ones. They can provide more effective treatments for patients with severe kidney failure. As a result, they are widely used in hospitals and dialysis clinic settings.
Growth Outlook by Key End User
| End User | Value CAGR |
|---|---|
| Hospitals | 1.6% |
| Clinics & Dialysis Centers | 3.4% |
| Ambulatory Surgical Centers | 2.1% |
| Home Care Settings | 4.5% |
The hospitals segment dominates the United States dialysis equipment business, holding around 36.0% value share in 2024. It will likely thrive at 1.6% CAGR, totaling US$ 2,730.0 million by 2034.
Rising patient inclination toward opting for dialysis treatments in hospitals due to presence of advanced technologies is expected to boost the target segment. Similarly, increasing number of hospitals offering dialysis services will foster segment growth.
Hospitals are well equipped to manage and treat co-existing health conditions that may be present alongside the need for dialysis treatment. This allows for a comprehensive approach to patient care and the coordination of treatment plans.
Hospitals are capable of providing emergency dialysis services to patients requiring immediate intervention or critical care. This makes them a vital end-user segment for the delivery of urgent dialysis treatment. Growing adoption of advanced kidney dialysis machines in hospital sector will foster segment growth.
Top manufacturers of dialysis equipment in the United States are focusing on developing technologically advanced solutions with enhanced features. They are also expanding their footprint by adopting strategies like partnerships, acquisitions, mergers, and alliances.
Recent Developments in the United States Dialysis Equipment Business
| Attribute | Details |
|---|---|
| Estimated Size (2024) | US$ 6,495.4 million |
| Projected Value (2034) | US$ 8,690.2 million |
| Anticipated Growth Rate (2024 to 2034) | 3.0% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Industry Analysis | US$ Million for Value |
| Key Regions Covered | Northeast, Midwest, Southeast, Southwest, and West |
| Key States Covered | New York, New Jersey, Massachusetts, Minnesota, Wisconsin, North Carolina, South Carolina, Florida, Virginia, Louisiana, Oklahoma, Texas, Washington, California, and New Mexico |
| Key Segments Covered | Product, Indication, modality, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Business Forecast, Competition Intelligence, DROT Analysis, Key Dynamics and Challenges, Strategic Growth Initiatives |
The United States business is valued at US$ 6,252.5 million in 2023.
Sales will likely total US$ 6,495.4 million by 2024.
Total business size is set to reach around US$ 8,690.2 million by 2034.
With 86.1% share, hemodialysis devices segment will dominate the target business.
The United States business grew at a 2.5% CAGR from 2019 to 2023.
Southeast is set to account for around 34.1% share of the United States business in 2024.
In the United States, the cost of a dialysis machine ranges from US$ 3000 to US$ 45000.
Dialyzer is mostly used for dialysis.
1. Executive Summary
1.1. Industry Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Industry Evolution
1.5. Analysis and Recommendations
2. Business Overview
2.1. Business Coverage / Taxonomy
2.2. Business Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Trends
3.1. Key Trends Impacting Sales Growth
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Installed Base Scenario
4.3. Disease Epidemiology -AKI, CKD, and ESRD
4.4. Regulatory Landscape
4.5. Reimbursement Scenario
4.6. PESTLE Analysis
4.7. Porter’s Analysis
4.8. Supply Chain Analysis
5. Business Background
5.1. Macro-Economic Factors
5.1.1. Healthcare Expenditure
5.1.2. R&D Funding
5.1.3. Medical Device Industry Outlook
5.1.4. Global Industry Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Prevalence of Diabetes and Hypertension
5.2.2. Advancements in Dialysis Technology
5.2.3. Home Dialysis and Remote Monitoring
5.2.4. Government Policies and Reimbursement
5.2.5. Patient Preference for Home Dialysis
5.2.6. Emerging Fields
5.2.7. Competitive Landscape
5.2.8. Aging Population
5.2.9. Global Health Crises
5.3. Key Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Business Volume (Units) Analysis, 2019 to 2023
6.2. Current and Future Business Volume (Units) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
7. Demand Pricing Analysis
7.1. Average Pricing Analysis Benchmark
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Pricing Assumptions
8. Demand (in Value or Size in US$ Million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
8.1. Revenue Opportunity Scenario
8.2. Historical Business Value (US$ Million) Analysis, 2019 to 2023
8.3. Current and Future Business Value (US$ Million) Projections, 2024 to 2034
8.3.1. Y-o-Y Growth Trend Analysis
8.3.2. Absolute $ Opportunity Analysis
9. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
9.1. Introduction / Key Findings
9.2. Historical Business Size (US$ Million) and Volume (Units) Analysis By Product, 2019 to 2023
9.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2024 to 2034
9.3.1. Hemodialysis Devices
9.3.1.1. Hemodialysis Machines
9.3.1.2. Dialyzers and Filters
9.3.1.3. Vascular access device
9.3.2. Peritoneal Dialysis Devices
9.3.2.1. Automated peritoneal dialysis Machine
9.3.2.2. Dialyzers and Filters
9.3.2.3. Vascular access device
9.3.3. Continuous Renal Replacement Therapy Systems
9.4. Industry Attractiveness Analysis By Product
10. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Modality
10.1. Introduction / Key Findings
10.2. Historical Business Size (US$ Million) Analysis By Modality, 2019 to 2023
10.3. Current and Future Business Size (US$ Million) Analysis and Forecast By Modality, 2024 to 2034
10.3.1. Portable Dialysis Systems
10.3.2. Standalone Dialysis Systems
10.4. Industry Attractiveness Analysis By Modality
11. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
11.1. Introduction / Key Findings
11.2. Historical Business Size (US$ Million) Analysis By Indication, 2019 to 2023
11.3. Current and Future Business Size (US$ Million) Analysis and Forecast By Indication, 2024 to 2034
11.3.1. Chronic Kidney Disease (CKD)
11.3.2. Acute Kidney Injury (AKI)
11.3.3. End Stage Renal Disease (ESRD)
11.4. Industry Attractiveness Analysis By Indication
12. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
12.1. Introduction / Key Findings
12.2. Historical Business Size (US$ Million) Analysis by End User, 2019 to 2023
12.3. Current and Future Business Size (US$ Million) Analysis and Forecast By End User, 2024 to 2034
12.3.1. Hospital
12.3.2. Clinics & Dialysis Centers
12.3.3. Ambulatory Surgical Centers
12.3.4. Home Care Setting
12.4. Industry Attractiveness Analysis by End User
13. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
13.1. Introduction
13.2. Historical Business Size (US$ Million) and Volume (Units) Analysis, By Region, 2019 to 2023
13.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2024 to 2034
13.3.1. Northeast
13.3.2. Midwest
13.3.3. Southeast
13.3.4. Southwest
13.3.5. West
13.4. Industry Attractiveness Analysis by Region
14. Northeast Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Business Size (US$ Million) and Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
14.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Industry Taxonomy, 2024 to 2034
14.3.1. By States
14.3.1.1. New York
14.3.1.2. New Jersey
14.3.1.3. Massachusetts
14.3.1.4. Rest of North East
14.3.2. By Product
14.3.3. By Modality
14.3.4. By Indication
14.3.5. By End User
14.4. Industry Attractiveness Analysis
14.4.1. By States
14.4.2. By Product
14.4.3. By Modality
14.4.4. By Indication
14.4.5. By End User
14.5. Drivers and Restraints - Impact Analysis
14.6. State Level Analysis & Forecast
14.6.1. New York Industry Analysis
14.6.1.1. Introduction
14.6.1.2. Industry Analysis and Forecast by Industry Taxonomy
14.6.1.2.1. By Product
14.6.1.2.2. By Modality
14.6.1.2.3. By Indication
14.6.1.2.4. By End User
14.6.2. New Jersey Industry Analysis
14.6.2.1. Introduction
14.6.2.2. Industry Analysis and Forecast by Industry Taxonomy
14.6.2.2.1. By Product
14.6.2.2.2. By Modality
14.6.2.2.3. By Indication
14.6.2.2.4. By End User
14.6.3. Massachusetts Industry Analysis
14.6.3.1. Introduction
14.6.3.2. Industry Analysis and Forecast by Industry Taxonomy
14.6.3.2.1. By Product
14.6.3.2.2. By Modality
14.6.3.2.3. By Indication
14.6.3.2.4. By End User
15. Midwest Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Business Size (US$ Million) and Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
15.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Industry Taxonomy, 2024 to 2034
15.3.1. By States
15.3.1.1. Minnesota
15.3.1.2. Wisconsin
15.3.1.3. Rest of Midwest
15.3.2. By Product
15.3.3. By Modality
15.3.4. By Indication
15.3.5. By End User
15.4. Industry Attractiveness Analysis
15.4.1. By States
15.4.2. By Product
15.4.3. By Modality
15.4.4. By Indication
15.4.5. By End User
15.5. States Level Analysis & Forecast
15.5.1. Minnesota Industry Analysis
15.5.1.1. Introduction
15.5.1.2. Industry Analysis and Forecast by Industry Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Modality
15.5.1.2.3. By Indication
15.5.1.2.4. By End User
15.5.2. Wisconsin Industry Analysis
15.5.2.1. Introduction
15.5.2.2. Industry Analysis and Forecast by Industry Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Modality
15.5.2.2.3. By Indication
15.5.2.2.4. By End User
16. Southeast Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Business Size (US$ Million) and Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
16.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Industry Taxonomy, 2024 to 2034
16.3.1. By States
16.3.1.1. North Carolina
16.3.1.2. South Carolina
16.3.1.3. Florida
16.3.1.4. Virginia
16.3.1.5. Rest of Southeast
16.3.2. By Product
16.3.3. By Modality
16.3.4. By Indication
16.3.5. By End User
16.4. Industry Attractiveness Analysis
16.4.1. By States
16.4.2. By Product
16.4.3. By Modality
16.4.4. By Indication
16.4.5. By End User
16.5. Drivers and Restraints - Impact Analysis
16.6. State Level Analysis & Forecast
16.6.1. North Carolina Industry Analysis
16.6.1.1. Introduction
16.6.1.2. Industry Analysis and Forecast by Industry Taxonomy
16.6.1.2.1. By Product
16.6.1.2.2. By Modality
16.6.1.2.3. By Indication
16.6.1.2.4. By End User
16.6.2. South Carolina Industry Analysis
16.6.2.1. Introduction
16.6.2.2. Industry Analysis and Forecast by Industry Taxonomy
16.6.2.2.1. By Product
16.6.2.2.2. By Modality
16.6.2.2.3. By Indication
16.6.2.2.4. By End User
16.6.3. Florida Industry Analysis
16.6.3.1. Introduction
16.6.3.2. Industry Analysis and Forecast by Industry Taxonomy
16.6.3.2.1. By Product
16.6.3.2.2. By Modality
16.6.3.2.3. By Indication
16.6.3.2.4. By End User
16.6.4. Virginia Industry Analysis
16.6.4.1. Introduction
16.6.4.2. Industry Analysis and Forecast by Industry Taxonomy
16.6.4.2.1. By Product
16.6.4.2.2. By Modality
16.6.4.2.3. By Indication
16.6.4.2.4. By End User
17. Southwest Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Business Size (US$ Million) and Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
17.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Industry Taxonomy, 2024 to 2034
17.3.1. By States
17.3.1.1. Louisiana
17.3.1.2. Oklahoma
17.3.1.3. Texas
17.3.1.4. Rest of Southeast
17.3.2. By Product
17.3.3. By Modality
17.3.4. By Indication
17.3.5. By End User
17.4. Industry Attractiveness Analysis
17.4.1. By States
17.4.2. By Product
17.4.3. By Modality
17.4.4. By Indication
17.4.5. By End User
17.5. Drivers and Restraints - Impact Analysis
17.6. State Level Analysis & Forecast
17.6.1. Louisiana Industry Analysis
17.6.1.1. Introduction
17.6.1.2. Industry Analysis and Forecast by Industry Taxonomy
17.6.1.2.1. By Product
17.6.1.2.2. By Modality
17.6.1.2.3. By Indication
17.6.1.2.4. By End User
17.6.2. Oklahoma Industry Analysis
17.6.2.1. Introduction
17.6.2.2. Industry Analysis and Forecast by Industry Taxonomy
17.6.2.2.1. By Product
17.6.2.2.2. By Modality
17.6.2.2.3. By Indication
17.6.2.2.4. By End User
17.6.3. Texas Industry Analysis
17.6.3.1. Introduction
17.6.3.2. Industry Analysis and Forecast by Industry Taxonomy
17.6.3.2.1. By Product
17.6.3.2.2. By Modality
17.6.3.2.3. By Indication
17.6.3.2.4. By End User
18. West Industry Analysis 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Business Size (US$ Million) and Volume (Units) Trend Analysis by Industry Taxonomy, 2019 to 2023
18.3. Current and Future Business Size (US$ Million) and Volume (Units) Analysis and Forecast By Industry Taxonomy, 2024 to 2034
18.3.1. By States
18.3.1.1. Washington
18.3.1.2. California
18.3.1.3. New Mexico
18.3.1.4. Rest of West
18.3.2. By Product
18.3.3. By Modality
18.3.4. By Indication
18.3.5. By End User
18.4. Industry Attractiveness Analysis
18.4.1. By States
18.4.2. By Product
18.4.3. By Modality
18.4.4. By Indication
18.4.5. By End User
18.5. Drivers and Restraints - Impact Analysis
18.6. State Level Analysis & Forecast
18.6.1. Washington Industry Analysis
18.6.1.1. Introduction
18.6.1.2. Industry Analysis and Forecast by Industry Taxonomy
18.6.1.2.1. By Product
18.6.1.2.2. By Modality
18.6.1.2.3. By Indication
18.6.1.2.4. By End User
18.6.2. California Industry Analysis
18.6.2.1. Introduction
18.6.2.2. Industry Analysis and Forecast by Industry Taxonomy
18.6.2.2.1. By Product
18.6.2.2.2. By Modality
18.6.2.2.3. By Indication
18.6.2.2.4. By End User
18.6.3. New Mexico Industry Analysis
18.6.3.1. Introduction
18.6.3.2. Industry Analysis and Forecast by Industry Taxonomy
18.6.3.2.1. By Product
18.6.3.2.2. By Modality
18.6.3.2.3. By Indication
18.6.3.2.4. By End User
19. Business Structure Analysis
19.1. Industry Analysis by Tier of Companies
19.2. Business Share Analysis of Top Players
20. Competition Analysis
20.1. Competition Benchmarking
20.2. Branding & Promotional Strategies by Key Players
20.3. Key Development Analysis
20.4. Competition Dashboard
20.5. Competition Deep Dive
20.5.1. Medtronic Plc.
20.5.1.1. Company Overview
20.5.1.2. Product Portfolio
20.5.1.3. Sales Footprint
20.5.1.4. Key Financials
20.5.1.5. SWOT Analysis
20.5.1.6. Key Developments
20.5.1.7. Strategy Overview
20.5.1.7.1. Channel Strategy
20.5.1.7.2. Marketing Strategy
20.5.1.7.3. Product Strategy
20.5.2. Baxter International, Inc.
20.5.3. B. Braun Melsungen AG
20.5.4. Asahi Kasei Corporation
20.5.5. Fresenius Medical Care (Fresenius SE & Co. KGaA)
20.5.6. Nipro Corporation
20.5.7. Toray Medical Co. Ltd. (Toray Industries, Inc.)
20.5.8. Allmed Medical Care
20.5.9. Dialife S.A
20.5.10. ESCO Medicon
20.5.11. Quanta Dialysis Technologies
20.5.12. Nikkiso Co., Ltd.
20.5.13. JMS Co. Ltd.
20.5.14. NxStage Medical, Inc.
20.5.15. NephroCan Holdings Corporation
20.5.16. Advin Urology
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Dialysis Equipment Industry Analysis in the United States
